We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
5901
Immunic
IMUX
$190M
$14K ﹤0.01%
117
+102
+680% +$10.4K
NEXT icon
5902
NextDecade
NEXT
$1.78B
$14K ﹤0.01%
6,494
-2,714
-29% -$4.96K
PFFR icon
5903
InfraCap REIT Preferred ETF
PFFR
$119M
$14K ﹤0.01%
700
PW
5904
Power REIT
PW
$3.01M
$14K ﹤0.01%
48
PXJ icon
5905
Invesco Oil & Gas Services ETF
PXJ
$65.9M
$14K ﹤0.01%
1,202
-911
-43% -$10.7K
DCOY
5906
Decoy Therapeutics
DCOY
$2.19M
0
TATT icon
5907
TAT Technologies
TATT
$505M
$14K ﹤0.01%
3,599
-3
-0.1% -$11
UYM icon
5908
ProShares Ultra Materials
UYM
$37.3M
$14K ﹤0.01%
1,204
+1,196
+14,950% +$12K
RBCN
5909
DELISTED
Rubicon Technology, Inc.
RBCN
$14K ﹤0.01%
1,726
-250
-13% -$1.95K
PTE
5910
DELISTED
PolarityTE, Inc. Common Stock
PTE
$14K ﹤0.01%
456
-2,815
-86% -$74.8K
ALO
5911
DELISTED
Alio Gold Inc
ALO
$14K ﹤0.01%
10,995
+7,995
+267% +$6.51K
OTTW
5912
DELISTED
Ottawa Bancorp, Inc. Common Stock
OTTW
$14K ﹤0.01%
1,301
SOIL
5913
DELISTED
Global X Fertilizers/Potash ETF
SOIL
$14K ﹤0.01%
1,950
-73
-4% -$504
JO
5914
DELISTED
iPath Series B Bloomberg Coffee Subindex Total ReturnSM ETN
JO
$14K ﹤0.01%
439
-90
-17% -$3K
AIRT icon
5915
Air T
AIRT
$75.5M
$13K ﹤0.01%
1,100
-584
-35% -$7.12K
BROG
5916
DELISTED
Brooge Energy
BROG
$13K ﹤0.01%
+1,500
New +$16.2K
DWAT
5917
DELISTED
Arrow Investments Trust Arrow DWA Tactical ETF
DWAT
$13K ﹤0.01%
1,300
EYLD icon
5918
Cambria Emerging Shareholder Yield ETF
EYLD
$838M
$13K ﹤0.01%
470
HOFV
5919
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$13K ﹤0.01%
65
HUSV icon
5920
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$75.9M
$13K ﹤0.01%
522
-149
-22% -$3.61K
IPO icon
5921
Renaissance IPO ETF
IPO
$153M
$13K ﹤0.01%
318
+250
+368% +$8.46K
IRS
5922
IRSA Inversiones y Representaciones
IRS
$1.29B
$13K ﹤0.01%
4,350
+568
+15% +$1.96K
IVLU icon
5923
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
$13K ﹤0.01%
688
-1,862
-73% -$35K
JQUA icon
5924
JPMorgan US Quality Factor ETF
JQUA
$8.21B
$13K ﹤0.01%
435
MSC
5925
Studio City International Holdings
MSC
$362M
$13K ﹤0.01%
840
-20
-2% -$318

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.